Rui Jiang

Corporate Secretary at JINKO SOLAR CO., LTD.

41 year

Process Industries

Consumer Services

Electronic Technology

Profile

Rui Jiang currently works at Cali Biosciences Co. Ltd., as Non-Executive Director from 2021 and Jinko Solar Co., Ltd., as Secretary from 2021.
Mr. Jiang also formerly worked at Bloomage Biotechnology Corp.
Ltd., as Board Secretary, Director & Deputy General Manager from 2019 to 2020.
Mr. Jiang received his graduate degree in 2008 from Renmin University of China.

Rui Jiang active positions

Companies	Position	Start
JINKO SOLAR CO., LTD.	Corporate Secretary	2021-01-06
Cali Biosciences Co. Ltd. Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China.	Director/Board Member	2021-03-16

All active positions of Rui Jiang

Former positions of Rui Jiang

Companies	Position	End
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED	Director/Board Member	2020-12-24

See the detail of Rui Jiang's experience

Training of Rui Jiang

Renmin University of China

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rui Jiang's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED	Process Industries
JINKO SOLAR CO., LTD.	Electronic Technology

Private companies	1
Cali Biosciences Co. Ltd. Cali Biosciences Co. Ltd. BiotechnologyHealth Technology Cali Biosciences Co. Ltd. operates as a biotechnology company dedicated to the research and development of new drugs for the perioperative space based on drug delivery platforms and other patented technologies. Its product focuses on non-opioid post-operative pain management, anti-inflammatory pain control, anesthesia, and sedation. The company was founded by Dibang Lin and Andrew Xian Chen on March 17, 2021 and is headquartered in Shenzhen, China.	Health Technology